Avidity Biosciences, Inc. Share Price
Stocks
RNAM
US05370A1088
Pharmaceuticals
|
Market Closed -
Nasdaq
02:30:00 27/02/2026 am IST
|
5-day change | 1st Jan Change | ||
| 72.82 USD | +0.03% |
|
-.--% | +0.96% |
| 22/10 | Pharma sector doubles down on AI to slash costs, timelines | RE |
| 19/10 | Pharma sector doubles down on AI to slash costs, timelines | RE |
| Market Cap | 1.13TCr 1.01TCr 932.04Cr 844.64Cr 1.58TCr 1,07300Cr 1.61TCr 11TCr 4.44TCr 56TCr 4.24TCr 4.15TCr 1,77200Cr | P/E 2024 |
-10.1x | P/E 2025 | -14.5x |
|---|---|---|---|---|---|
| Enterprise Value | 965.04Cr 861.78Cr 796.12Cr 721.46Cr 1.35TCr 92TCr 1.37TCr 9.58TCr 3.79TCr 48TCr 3.62TCr 3.54TCr 1,51300Cr | EV / Sales 2024 |
181x | EV / Sales 2025 | 492x |
| Free-Float |
10.55% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Avidity Biosciences, Inc.
| 1 day | +0.03% | ||
| Current year | +0.96% |
| Current year | 72 |  | 73.06 |
| 1 year | 69.5 | | 73.06 |
| 3 years | 4.82 | | 73.06 |
| 5 years | 4.82 | | 73.06 |
| 10 years | 4.82 | | 73.06 |
| Manager | Title | Age | Since |
|---|---|---|---|
John McKenna
PSD | President | - | 27/02/2026 |
Eduard Marti
TRE | Treasurer | - | 27/02/2026 |
Jaime S. Huertas
SEC | Corporate Secretary | - | 27/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Jaime S. Huertas
BRD | Director/Board Member | - | 27/02/2026 |
Eduard Marti
BRD | Director/Board Member | - | 27/02/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 27/02/26 | Issuer sale | Director | 1,10,073 | 0.0766% | ||
| 27/02/26 | Issuer sale | Chief Technology Officer | 5,47,865 | 0.3814% | ||
| 27/02/26 | Issuer sale | General Counsel | 3,02,054 | 0.2103% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.03% | -.--% | +48.16% | +1,287.05% | 1.13TCr | |
| -2.54% | +1.31% | +54.27% | +114.96% | 1,13500Cr | |
| -1.42% | +3.23% | +38.56% | +74.44% | 64TCr | |
| +0.16% | +0.08% | +25.29% | +95.23% | 50TCr | |
| -0.31% | +3.09% | +44.14% | +64.80% | 38TCr | |
| -1.34% | -0.47% | +66.04% | +41.00% | 36TCr | |
| -0.68% | +2.65% | +22.98% | +50.39% | 29TCr | |
| -1.20% | +3.04% | +2.33% | +22.86% | 27TCr | |
| -1.79% | +1.57% | +50.56% | +59.08% | 24TCr | |
| -0.73% | -0.10% | +29.02% | +99.67% | 19TCr | |
| Average | -0.98% | +1.95% | +38.13% | +190.95% | 40.15TCr | |
| Weighted average by Cap. | -1.34% | +2.65% | +41.04% | +83.15% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.09Cr 97.31L 89.9L 81.47L 1.52Cr 103.44Cr 1.55Cr 11Cr 4.28Cr 54Cr 4.09Cr 4Cr 170.87Cr | 1.88Cr 1.67Cr 1.55Cr 1.4Cr 2.62Cr 178.04Cr 2.67Cr 19Cr 7.37Cr 93Cr 7.04Cr 6.89Cr 294.09Cr |
| Net income | -32Cr -29Cr -27Cr -24Cr -45Cr -3.06TCr -46Cr -319.96Cr -126.67Cr -1.6TCr -120.96Cr -118.38Cr -5.05TCr | -68Cr -61Cr -56Cr -51Cr -96Cr -6.5TCr -97Cr -679.65Cr -269.08Cr -3.41TCr -256.94Cr -251.47Cr -11TCr |
| Net Debt | -149.47Cr -133.48Cr -123.31Cr -111.74Cr -209.06Cr -14TCr -212.52Cr -1.48TCr -587.46Cr -7.43TCr -560.94Cr -549.02Cr -23TCr | -164.76Cr -147.13Cr -135.92Cr -123.18Cr -230.45Cr -16TCr -234.26Cr -1.64TCr -647.56Cr -8.19TCr -618.33Cr -605.19Cr -26TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- RNAM Stock
Select your edition
All financial news and data tailored to specific country editions
